Oppenheimer Initiates Coverage on International Business Machines Corp (IBM)

2 min readBy Investing Point

Oppenheimer has initiated coverage on International Business Machines Corp (IBM), assigning an Outperform rating. This marks the firm's first assessment of IBM's investment potential based on a thorough analysis of the company's business operations, industry dynamics, and growth prospects.

As of November 20, 2025, IBM's stock trades at $296.31, with a market capitalization of $281.0 billion. The company, headquartered in Armonk, New York, operates across various segments, including Software, Consulting, Infrastructure, and Financing. Its Software segment focuses on hybrid cloud and AI platforms, while the Consulting segment integrates expertise across strategy, technology, and operations. The Infrastructure segment targets the hybrid cloud infrastructure market, offering both on-premises and cloud-based solutions.

Analyst ratings, such as this one from Oppenheimer, provide insights based on extensive research and financial modeling. While they can inform investment decisions, they are based on assumptions that may not always materialize. Investors should consider a range of factors, including company fundamentals and market trends, rather than relying solely on analyst opinions.

IBM is expected to report its upcoming earnings on July 21, 2026, with an estimated EPS of $3.04 and revenue of $17.8 billion. The company's recent earnings performance has shown positive surprises, including a Q3 2025 EPS of $2.65, exceeding estimates by 7.3%.

As analyst ratings can evolve with new information, it's essential for investors to stay informed about any changes in outlook from various analysts.

This brief was generated from structured financial data and reviewed by the Investing Point editorial team. It is for informational purposes only and does not constitute investment advice. Market data provided by Finnhub.

Related Stocks

More in this Category

Analyst Ratings

Explore more analyst ratings or view detailed analysis for IBM stock.